反応式
Br[C:2]1[CH:30]=[CH:29][C:28]([F:31])=[CH:27][C:3]=1[CH2:4][N:5]1[C:10](=[O:11])[C:9]([CH3:12])=[N:8][N:7]=[C:6]1[N:13]1[CH2:18][CH2:17][CH2:16][C@@H:15]([NH:19]C(=O)OC(C)(C)C)[CH2:14]1.C(O)(C(F)(F)F)=O.C([O-])(O)=O.[Na+]>ClCCl>[NH2:19][C@@H:15]1[CH2:16][CH2:17][CH2:18][N:13]([C:6]2[N:5]([CH2:4][C:3]3[CH:2]=[CH:30][CH:29]=[C:28]([F:31])[CH:27]=3)[C:10](=[O:11])[C:9]([CH3:12])=[N:8][N:7]=2)[CH2:14]1参加物
5
実験手順
To a solution of (R)-tert-butyl 1-(4-(2-bromo-5-fluorobenzyl)-6-methyl-5-oxo-4,5-dihydro-1,2,4-triazin-3-yl)piperidin-3-ylcarbamate (18, 30 mg) in dichloromethane (1 mL) was added TFA (0.5 mL), and the mixture was stirred at RT for 3 h. The mixture was carefully neutralized with NaHCO3 (aq, saturated), and extracted with CH2Cl2 (10 mL×3). The combined extracts were dried over Na2SO4 and concentrated to give the crude product. This was purified by column chromatography on silica gel, and eluted with 92:6:2 dichloromethane-methanol-ammonia to provide (R)-3-(3-aminopiperidin-1-yl)-4-(3-fluorobenzyl)-6-methyl-1,2,4-triazin-5(4H)-one (19). MS: m/z, 396 (100%, M+1), 398 (100%).
後処理
- extractionextracted with CH2Cl2 (10 mL×3)
- dry with materialThe combined extracts were dried over Na2SO4
- concentrationconcentrated
- customto give the crude product
- customThis was purified by column chromatography on silica gel
- washeluted with 92:6:2 dichloromethane-methanol-ammonia
出典と根拠
- ORDレコード
- ord-005f7eeefaa94590b480d68baa0784dc
- 出典データセット
- uspto-grants-2014_02
- 特許番号
- US08648073B2
関連ノート
読み込み中…